e-learning
resources
Virtual 2020
Wednesday, 09.09.2020
Ageing, metabolic syndrome and the lung
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD as a risk factor for carotid artery disease (CAD) and low-extremity artery disease (LEAD)
D. Buklioska Ilievska (Skopje), J. Minov (Skopje), N. Kochovska Kamchevska (Skopje), M. Baloski (Skopje), B. Poposki (Skopje)
Source:
Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Session:
Ageing, metabolic syndrome and the lung
Session type:
Oral Presentation
Number:
5118
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Buklioska Ilievska (Skopje), J. Minov (Skopje), N. Kochovska Kamchevska (Skopje), M. Baloski (Skopje), B. Poposki (Skopje). COPD as a risk factor for carotid artery disease (CAD) and low-extremity artery disease (LEAD). 5118
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Underappreciation of coronary artery disease in patients with COPD
Source: Virtual Congress 2020 – Ageing, metabolic syndrome and the lung
Year: 2020
OSA and coronary artery disease
Source: Sleep and Breathing Conference 2021
Year: 2021
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Prevalence of chronic obstructive pulmonary disease (COPD) among smokers with stable coronary artery disease (CAD)
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Assessment of cardiovascular comorbidity
Source: Eur Respir Mon 2013; 59: 28-49
Year: 2013
Remodeling of common carotid and common femoral arteries in COPD patients without previously diagnosed cardiovascular diseases (CVD).
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018
The risk of development of coronary artery disease and 10 years Systemic Coronary Risk Evaluation at patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
Lower extremity and carotid artery disease in COPD
Source: ERJ Open Res, 2 (4) 00037-2016; 10.1183/23120541.00037-2016
Year: 2016
Visual estimate of coronary artery calcium predicts cardiovascular disease in COPD
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Dyspnea in patients with coronary artery disease: is it related with physiologic measurements?
Source: Eur Respir J 2001; 18: Suppl. 33, 300s
Year: 2001
Endothelial function in COPD vs coronary artery disease and healthy controls: An exploratory study
Source: International Congress 2016 – Multidimensional and multidisciplinary approaches to respiratory problems
Year: 2016
Lipid profile in COPD patients with coronary artery disease comorbidity
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013
COPD is an indipendent risk factor for in-situ pulmonary artery thrombosis
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
The frequency of combination of chronic obstructive pulmonary disease and coronary artery disease
Source: Eur Respir J 2006; 28: Suppl. 50, 625s
Year: 2006
Current symptom-based risk scores for stable coronary artery disease evaluation are not applicable in COPD patients
Source: ERJ Open Res, 6 (4) 00492-2020; 10.1183/23120541.00492-2020
Year: 2020
COPD is associated with an increased risk of peripheral artery disease and mortality
Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
Year: 2018
Heart failure and coronary artery disease in lung disease
Source: International Congress 2018 – PG19 Heart-lung interaction
Year: 2018
Increased risk of stroke in patients with coronary artery disease and sleep apnea – a 10 year follow-up.
Source: Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Year: 2008
Comparison of cardiopulmonary exercise test in COPD patients with and without coronary artery disease
Source: Annual Congress 2013 –The best posters in exercise testing and physical inactivity
Year: 2013
Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up
Source: Eur Respir J 2006; 28: 596-602
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept